<DOC>
	<DOCNO>NCT01564992</DOCNO>
	<brief_summary>This observational study aim identify gene modifier Parkinson Disease ( PD ) treatment response adverse event antiparkinsonian drug . Six hundred PD patient follow annually 5 year . A biological collection associate full clinical assessment motor non motor symptom , medical treatment history , environmental factor . The association candidate gene polymorphisms disease treatment complication analyze .</brief_summary>
	<brief_title>Drug Interaction With Genes Parkinson 's Disease</brief_title>
	<detailed_description>Title : Drug interaction gene Parkinson Disease Objective : To identify gene associate disease treatment complication response . Number subject : 500 Study duration : 6 year Design : Prospective cohort biological collection Primary objective : Identification gene polymorphism haplotype associate complication Parkinson disease , directly interaction treatment . Secondary objective : - Prevalence incidence disease treatment complication - Clinical risk factor disease treatment complication - Biomarkers disease progression , disease treatment complication</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Men woman , age &gt; 18 . Parkinson Disease accord UKPDSBB criterion PD diagnosis &lt; 6 year Informed consent Atypical parkinsonism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Pharmacogenetics</keyword>
	<keyword>Genetics</keyword>
</DOC>